| Results summary | View all lists in GO:BiolProc | View all genes in S01CB.profile.ud50 |
|
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. enrichment: 2.03-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 212849_AT | AXIN1 | G | D | P | S | axin 1 | |||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 217997_AT | PHLDA1 | G | pleckstrin homology-like domain, family A, member 1 | ||||||||||
| 212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
| 202923_S_AT | GCLC | G | X | E | R | glutamate-cysteine ligase, catalytic subunit | |||||||
| 215990_S_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 203373_AT | SOCS2 | G | S | suppressor of cytokine signaling 2 | |||||||||
| 204999_S_AT | ATF5 | G | R | activating transcription factor 5 | |||||||||
| 212593_S_AT | PDCD4 | G | R | programmed cell death 4 (neoplastic transformation inhibitor) | |||||||||
| 205655_AT | MDM4 | G | P | R | Mdm4, transformed 3T3 cell double minute 4, p53 binding protein (mouse) | ||||||||
| 200797_S_AT | MCL1 | G | D | S | myeloid cell leukemia sequence 1 (BCL2-related) | ||||||||
| 222152_AT | PDCD6 | G | programmed cell death 6 | ||||||||||
| 205409_AT | FOSL2 | R | FOS-like antigen 2 | ||||||||||
| 201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
| 205067_AT | IL1B | G | X | P | C | S | interleukin 1, beta | ||||||
| 209120_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
| 211833_S_AT | BAX | G | T | D | X | P | S | BCL2-associated X protein | |||||